Pausing tirzepatide during moderate to severe COVID-19 is often recommended, especially if you're experiencing nausea, vomiting, or poor oral intake
Members who have already completed Kaiser's behavioral program or who have documented failed trials of other anti-obesity medications can compress this timeline to 4 to 6 weeks from specialist referral to PA decision
doi:10.1016/S0140-6736(11)60205-5
With FDA approval specifically for diabetes, Mounjaro helps individuals maintain healthy blood sugar levels
Supporting Healthy Hair Throughout Your Weight Loss Journey Hair thinning during GLP-1 treatment can be concerning, but for most people, its a temporary response to rapid weight loss rather than a permanent side effect
An exercise prescription People with PAD may be hesitant to walk, believing their leg pain is harmful